Patents Represented by Attorney Karen Cochran
  • Patent number: 7304047
    Abstract: This invention relates to a method of treating Substance Use such as Substance Abuse or Substance Dependence and in particular to the use of quetiapine in treating such disorders.
    Type: Grant
    Filed: February 5, 2002
    Date of Patent: December 4, 2007
    Assignee: AstraZeneca AB
    Inventor: Sherwood Brown
  • Patent number: 7022692
    Abstract: Granule formulation of quetiapine and pharmaceutically acceptable salt thereof are described, as are their preparation and their use in treating diseases of the central nervous system such as psychotic disease conditions including schizophrenia.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: April 4, 2006
    Assignee: AstraZeneca AB
    Inventor: Daniel Boyd Brown
  • Patent number: 6903092
    Abstract: Compounds having the general formula wherein R1, R2, R3, R4, R5, X1 and X2 are as defined in the specification, methods of using such compounds for the treatment of diseases and pharmaceutical composition comprising such compounds.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: June 7, 2005
    Inventor: Peter Bernstein
  • Patent number: 6821973
    Abstract: A compound having the general formula R1R2N—CH2CH2—CHAr1—CH2—NR3—CO—R4  (I) and methods of using such compounds for the treatment of diseases and pharmaceutical composition comprising such compounds.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: November 23, 2004
    Assignee: Astrazeneca AB
    Inventor: Peter Robert Bernstein